ArkeaBio vs 100ms
Side-by-side comparison of AI visibility scores, market position, and capabilities
$40M+ total raised including $26.5M Series A. 2026-27 cattle field trials underway. Backed by Breakthrough Energy Ventures. Only company with a cattle methane vaccine in active trials.
About
ArkeaBio is developing a vaccine that reduces methane emissions from cattle and sheep by targeting the methanogenic archaea (ancient microorganisms) that produce methane in ruminant digestive systems. The company has raised $40 million+ including a $26.5 million Series A, backed by Breakthrough Energy Ventures and Gates Foundation-aligned capital, and has active cattle field trials underway in 2026-2027 — making it the only company with a livestock methane vaccine at this stage of clinical development.
100ms is a live audio/video infrastructure platform with SDKs for React, iOS, Android, and Flutter, providing programmable rooms, recording, and live streaming for web and mobile apps.
About
100ms is a live audio and video infrastructure platform that provides developers with SDKs and APIs for embedding real-time communication features — video rooms, audio spaces, live streams, and recording — into web and mobile applications. The platform is designed around a room-based model where developers programmatically create, configure, and manage video rooms through a REST API, with client SDKs for React, iOS, Android, Flutter, and React Native handling the media layer. This abstraction allows teams to build fully custom video experiences with their own UI without dealing with WebRTC internals, TURN server management, or media server infrastructure.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.